ライフサイエンスコーパス: movement disorder

1 udies had motor symptoms (either weakness or movement disorder).

2 essential tremor than in subjects without a movement disorder.

3 's disease is a debilitating, age-associated movement disorder.

4 se (PD), the most frequent neurodegenerative movement disorder.

5 se (PD) is the most common neurodegenerative movement disorder.

6 enerative disease that causes a debilitating movement disorder.

7 d in primary dystonia, an autosomal-dominant movement disorder.

8 motor neurons degenerate and cause a spastic movement disorder.

9 craniocervical dystonia and humans without a movement disorder.

10 h that from individuals with no history of a movement disorder.

11 , thin habitus, hypotonia, and a nonspecific movement disorder.

12 sia (PNKD) is an autosomal dominant episodic movement disorder.

13 epilepsy, intellectual disability (ID), and movement disorder.

14 pain in conjunction with bloating and bowel movement disorder.

15 dominant manner to onset of a characteristic movement disorder.

16 cognitive function in addition to causing a movement disorder.

17 s disease (PD), the most common degenerative movement disorder.

18 these changes in patients with hyperkinetic movement disorders.

19 ssential tremor (ET) are the two most common movement disorders.

20 tual disability, postnatal microcephaly, and movement disorders.

21 type-genotype overlap among these paroxysmal movement disorders.

22 for many patients with advanced PD and other movement disorders.

23 sed to alleviate the symptoms of a number of movement disorders.

24 tter can also cause psychiatric symptoms and movement disorders.

25 graines and a variety of ocular motility and movement disorders.

26 , autism, depression, anxiety, addiction and movement disorders.

27 ment is impaired in patients with functional movement disorders.

28 se and essential tremor, the two most common movement disorders.

29 drug abuse, as well as neuropsychiatric and movement disorders.

30 bilitation of patients with supranuclear eye movement disorders.

31 ssociation of basal ganglia dysfunction with movement disorders.

32 data needed to understand human movement and movement disorders.

33 t others represent delayed-onset progressive movement disorders.

34 new therapeutic strategies for certain human movement disorders.

35 for miR-128 in the treatment of epilepsy and movement disorders.

36 damage may cause directionally selective eye movement disorders.

37 ely applied to uncover genetic mechanisms of movement disorders.

38 how disturbances in neural activity produce movement disorders.

39 ial tremor (ET) is one of the most prevalent movement disorders.

40 ork imaging and its clinical applications in movement disorders.

41 receive the most attention for their role in movement disorders.

42 n the study of Parkinson disease and related movement disorders.

43 nectivity in Parkinson's disease and related movement disorders.

44 eurosurgery for use in medication-refractory movement disorders.

45 al field potentials in the three most common movement disorders.

46 phthalmologist in diagnosis and treatment of movement disorders.

47 , atypical parkinsonian syndromes, and other movement disorders.

48 t and determining prognosis in patients with movement disorders.

49 bute to basal ganglia dysfunction in several movement disorders.

50 s are very efficient to control epilepsy and movement disorders.

51 contribute to both epilepsy and hyperkinetic movement disorders.

52 importance of the ERK/MAPK pathway in human movement disorders.

53 treatments for chorea and other hyperkinetic movement disorders.

54 ity can contribute to the pathophysiology of movement disorders.

55 buting to the development and progression of movement disorders.

56 ncluding varying therapeutic efficacy across movement disorders.

57 henotype detection in experimental models of movement disorders.

58 the pathophysiology of basal-ganglia-related movement disorders.

59 ce of a distinct entity called periodic limb movements disorder.

60 Two adults had encephalopathy with movement disorder, 1 had encephalitis, and 1 had Guillai

61 6 subjects were studied, 13 with psychogenic movement disorders, 11 with organic movement disorders a

62 n 30 patients with GLUT1-DS with predominant movement disorders, 18 patients with movement disorders

63 Thirty-one studies treated movement disorders, 22 treated disorders of consciousnes

64 , behavioural change (63%), confusion (50%), movement disorder (38%) and hallucinations (25%) were co

65 77.4%-95.0%, respectively) and subjects with movement disorders (67.0%-97.9% and 71.4%-98.4%, respect

66 In patients with paroxysmal movement disorders 68 families had mutations (47%) out o

67 Twelve children had encephalopathy (1 with movement disorder), 8 had encephalitis, and 1 had mening

68 haracteristic of the G1D syndrome, including movement disorders, absence epilepsy (typical and atypic

69 se (PD) is the most common neurodegenerative movement disorder, affecting 1% of the population over 6

70 Essential tremor (ET) is the most prevalent movement disorder, affecting millions of people in the U

71 ment of any body part, is the most prevalent movement disorder, affecting millions of people in the U

72 rt, is often professed to be the most common movement disorder, affecting up to one percent of adults

73 Cranial movement disorders--affecting the eyes, face, jaw, tongu

74 he parasite-brain interactions and epilepsy, movement disorders, Alzheimer's disease, and cancer.

75 syndrome, was the most common extrapyramidal movement disorder among pediatric patients with mitochon

76 analyzed a cohort of patients with atypical movement disorder and identified 2 DAT coding variants,

77 s the most common cause of neurodegenerative movement disorder and the second most common cause of de

78 Parkinson disease (PD) is the most common movement disorder and, although the exact causes are unk

79 chogenic movement disorders, 11 with organic movement disorders and 12 normal controls.

80 e bead task', in 18 patients with functional movement disorders and 18 healthy agematched controls.

81 neurologic disorders, most often related to movement disorders and disorders of consciousness.

82 The etiology of many severe childhood movement disorders and epilepsies remains uncharacterize

83 ry queues or reduce symptoms associated with movement disorders and increasingly for psychological an

84 rial at the University of Florida Center for Movement Disorders and Neurorestoration clinic (Gainesvi

85 Developments in functional neurosurgery for movement disorders and recent advances in electrophysiol

86 several neuropsychiatric disorders, such as movement disorders and schizophrenia.

87 egions of the brain, resulting in paroxysmal movement disorders and seizure phenotypes.

88 progressive neurological symptoms, including movement disorders and spasticity.

89 plete knowledge about the pathophysiology of movement disorders and their influence on normal motor d

90 BG, is correlated to the onset of PD-related movement disorders and thus has been proposed to be a ke

91 n reported in response to PAS in people with movement disorders and to changes in healthy individuals

92 hich is a necessary first step to understand movement disorders and to create patient-specific surgic

93 dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs.

94 ures (including severe gut dysmotility and a movement disorder) and electrographic features including

95 ambulation, near-complete correction of the movement disorder, and resumption of development.

96 sease (PD) is the most prevalent hypokinetic movement disorder, and symptomatic PD pathogenesis has b

97 STN effectively alleviate motor symptoms in movement disorders, and cholinergic stimulation boosts t

98 der that manifests with personality changes, movement disorders, and cognitive decline.

99 ar diseases represent up to 22% of secondary movement disorders, and involuntary movements develop af

100 tion-refractory hypokinetic and hyperkinetic movement disorders, and it is being explored for a varie

101 s of infancy, including epilepsy, paroxysmal movement disorders, and migraine.

102 l and muscular processing such as paralysis, movement disorders, and muscular weakness.

103 al delay, intellectual disability, epilepsy, movement disorders, and neurodegeneration, among others.

104 (D2R) and are implicated in drug addiction, movement disorders, and nociception.

105 disorders such as schizophrenia, functional movement disorders, and Parkinson's disease.

106 evere intellectual deficiency, microcephaly, movement disorders, and/or early-onset intractable epile

107 The signs and symptoms of movement disorders appear to result largely from signatu

108 Neurologists should be aware that many movement disorders are immune-mediated.

109 a better pathophysiological understanding of movement disorders as complex alterations of widespread

110 volumes, in addition to onset of diagnosable movement disorder, as major outcome measures.

111 Extrapyramidal movement disorders associated with mitochondrial disease

112 , using the search terms Parkinson's disease,movement disorders, ataxia, dystonia, chorea, and Creutz

113 ominant movement disorders, 18 patients with movement disorders attributed to other genetic defects,

114 various other features including hypotonia, movement disorders, behavior problems, corpus callosum h

115 ogical conditions (most notably epilepsy and movement disorders), but widespread use is limited by co

116 clinically recognized to treat parkinsonian movement disorders, but its mechanisms remain elusive.

117 Hyperkinetic states are common in human movement disorders, but their neural basis remains uncer

118 cally similar to those of subjects without a movement disorder by reducing excess sensorimotor cortic

119 delay the deterioration of motor function in movement disorders by blocking aberrant motor learning.

120 ychogenic' has been replaced by 'functional' movement disorders by many authors in the field to expre

121 or therapies that aim to treat basal ganglia movement disorders by normalizing firing patterns.

122 This movement disorder can be recalcitrant to recovery.

123 Post-stroke movement disorders can manifest in parkinsonism or a wid

124 Movement disorders can occur as primary (idiopathic) or

125 disorders cases, 4/11 (36%) non-psychogenic movement disorders cases and 4/12 (33%) controls (p=0.04

126 spasm was present in 9/13 (69%) psychogenic movement disorders cases, 4/11 (36%) non-psychogenic mov

127 ital neutropenia, progressive brain atrophy, movement disorder, cataracts, and 3-methylglutaconic aci

128 cephalopathy with progressive brain atrophy, movement disorder, cataracts, and early death.

129 and the etiology of DYT1 primary dystonia, a movement disorder caused by a single glutamate deletion

130 DYT1 is a debilitating movement disorder caused by loss-of-function mutations i

131 ion dystonia (DYT1 dystonia) is an inherited movement disorder caused by mutations in one allele of D

132 Myoclonus-dystonia (M-D) is a very rare movement disorder, caused in approximately 30-50% of cas

133 ne conditions at the Parkinson's Disease and Movement Disorders Center of Northwestern University.

134 nal study of 44 participants at 17 different movement disorder centers who were in the Consortium on

135 Essential tremor (ET), a movement disorder characterised by an uncontrollable sha

136 Myoclonus-dystonia (M-D) is a rare movement disorder characterized by a combination of non-

137 Parkinson's disease (PD) is a movement disorder characterized by a progressive loss of

138 Parkinson's disease is a movement disorder characterized by death of dopaminergic

139 Dystonia is typically considered a movement disorder characterized by motor manifestations,

140 DYT11 myoclonus-dystonia (M-D) is a movement disorder characterized by myoclonic jerks with

141 a syndrome is a childhood onset hyperkinetic movement disorder characterized by predominant alcohol r

142 Dystonia is a movement disorder characterized by repetitive twisting m

143 se rapid-onset dystonia-parkinsonism, a rare movement disorder characterized by sudden onset of dysto

144 Dystonia is a movement disorder characterized by sustained or intermit

145 Progressive supranuclear palsy (PSP) is a movement disorder characterized by tau neuropathology wh

146 Parkinson's disease (PD) is a major movement disorder characterized by the loss of dopamine

147 ociation study of essential tremor, a common movement disorder characterized mainly by a postural and

148 re recruited for 18F-DTBZ PET scans from the Movement Disorders Clinic in the Chang Gung Memorial Hos

149 A cross-sectional study at an academic movement disorders clinic that included a predominantly

150 The cohorts were from 2 movement disorders clinics in Montreal, Quebec, Canada (

151 rom 1549 patients with PD recruited across 5 movement disorders clinics located in Europe, Israel, an

152 cessary when a patient with a combination of movement disorders, cognitive decline, behavioural abnor

153 s a progressive and devastating degenerative movement disorder commonly associated with loss of cereb

154 PURPOSE OF REVIEW: Movement disorders commonly present with ocular features

155 Movement disorders commonly present with ocular features

156 etraction syndrome (DRS) is a congenital eye-movement disorder defined by limited outward gaze and re

157 ing a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism.

158 have been described in other childhood-onset movement disorders, different forms of seizures, headach

159 Many movement disorders disrupt motor unit contractile dynami

160 cular motor system and lead to the human eye movement disorder, Duane retraction syndrome (DRS).

161 from two families affected by a hyperkinetic movement disorder due to homozygous mutations c.320A>G (

162 A common form of the hyperkinetic movement disorder dystonia is caused by mutations in the

163 UBB6, one of which (TUBB4) is mutated in the movement disorder dystonia type 4 (DYT4).

164 In DCP, two major movement disorders, dystonia and choreoathetosis, are pr

165 py for the management of treatment-resistant movement disorders, epilepsy and neuropsychiatric disord

166 sidered in patients with undiagnosed complex movement disorders even in the absence of a family histo

167 tandard is the clinical evaluation made by a movement disorders expert.

168 were scored blindly and independently by two movement-disorders experts.

169 Functional (psychogenic) movement disorders (FMD) are part of the wide spectrum o

170 g and management of functional (psychogenic) movement disorders (FMD).

171 ogical mechanism of functional (psychogenic) movement disorders (FMDs).

172 is involved in several neuropsychiatric and movement disorders for which a dysfunctional signaling o

173 ease (PD) is a progressive neurodegenerative movement disorder frequently associated with a wide vari

174 entional MR imaging-guided DBS placement for movement disorders from September 2013 to August 2014 fo

175 cally for the treatment of anxiety, obesity, movement disorders, glaucoma, and pain.

176 or psychogenic) motor symptoms (weakness and movement disorder) has not been systematically reviewed.

177 investigate whether patients with functional movement disorders have abnormalities in probabilistic r

178 These movement disorders have been encountered in patients wit

179 ng of gait compared to lesions causing other movement disorders (hemichorea or asterixis).

180 In addition, the nonepileptic paroxysmal movement disorder hyperekplexia has not previously been

181 sonism was the most prevalent extrapyramidal movement disorder in adults and was commonly associated

182 of a congenital intellectual disability and movement disorder in humans.

183 Movement disorders in children are causally and clinical

184 e findings reveal that gut bacteria regulate movement disorders in mice and suggest that alterations

185 l as radiological findings in the context of movement disorders in mitochondrial disease.

186 e >/=20 years) from two clinics for tertiary movement disorders in the UK.

187 , 2010, at 15 clinical sites specialising in movement disorders in the USA.

188 ed with the mutant human ATG5 exhibit severe movement disorder, in contrast to flies expressing the w

189 The sensory aspects of movement disorders include intrinsic sensory abnormaliti

190 rimental to the cerebellum and can result in movement disorders including ataxias.

191 parkinsonism or a wide range of hyperkinetic movement disorders including chorea, ballism, athetosis,

192 is an established neurosurgical therapy for movement disorders including essential tremor and Parkin

193 The diagnosis of movement disorders including Parkinson's disease (PD) an

194 cribe a disease encompassing infantile-onset movement disorder (including severe parkinsonism and non

195 expression of RGMa resulted in a progressive movement disorder, including motor coordination and imba

196 Parkinson's disease (PD) is characterized by movement disorders, including bradykinesia.

197 nosis for both infantile- and juvenile-onset movement disorders, including cerebral palsy and juvenil

198 de a comprehensive review of DBS focusing on movement disorders, including the historical evolution o

199 Tardive dyskinesia is a persistent movement disorder induced by dopamine receptor blockers,

200 l to transfer the expanding knowledge of the movement disorders into the development of novel symptom

201 The pathophysiology of both movement disorders is largely unknown.

202 l drugs to provide symptomatic relief of the movement disorders is limited by adverse effects and the

203 expanded, appreciation of cranial functional movement disorders is still insufficient.

204 s disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of m

205 rkinson's disease, typically thought of as a movement disorder, is increasingly recognized as causing

206 gy of essential tremor (ET), the most common movement disorder, is not fully understood.

207 ilon-sarcoglycan (SGCE) cause the neurogenic movement disorder myoclonus dystonia syndrome.

208 Initial misdiagnoses included functional movement disorder (n = 2), generalized dystonia and park

209 with essential tremor (n = 9) and without a movement disorder (n = 6).

210 Isolated focal dystonia is a debilitating movement disorder of unknown pathophysiology.

211 Movement disorders of basal ganglia origin may arise fro

212 Essential tremor is one of the most frequent movement disorders of humans and can be associated with

213 in two control groups (patients with organic movement disorders (OMD) and healthy volunteers).

214 a 3-year-old boy who presented with a mixed movement disorder (opsoclonus, ataxia, and chorea) as we

215 more of neuropsychiatric symptoms, seizures, movement disorder or cognitive dysfunction, were identif

216 e standard, was high in subjects with either movement disorders or dementia and was similar in on-sit

217 opriate clinical management of patients with movement disorders or dementia.

218 ildren and adults with cognitive impairment, movement disorder, or epilepsy.

219 eports on RAD51-associated congenital mirror movement disorders, our results point to an important ro

220 cosmetic applications, treatment of various movement disorders, pain and many other syndromes, and f

221 The hallmark of the movement disorder Parkinson's disease (PD) is progressiv

222 rtical oscillations in the three most common movement disorders: Parkinson's disease, primary dystoni

223 and with 1 or more predefined extrapyramidal movement disorders (parkinsonism, dystonia, tremor, chor

224 t in the clinical examination of psychogenic movement disorders patients.

225 The recognition of the particular movement disorder phenotype, coupled with information ab

226 HL), 20 with BIISS and 20 with periodic limb movement disorder (PLMD).

227 Psychogenic movement disorders (PMDs) may be difficult to differenti

228 sia (PNKD) is an autosomal dominant episodic movement disorder precipitated by coffee, alcohol, and s

229 neurodegenerative diseases characterized by movement disorders, psychiatric disturbances and cogniti

230 cognitive and behavioral problems, seizures, movement disorders, psychiatric features, and demyelinat

231 phalopathy, refractory seizures, and a mixed movement disorder rather than limbic encephalitis.

232 e been used to a greater extent for mood and movement disorders, recent work has explored brain stimu

233 al management of patients with a challenging movement disorder referred to as focal hand dystonia (FH

234 ype associations and deep phenotyping of the movement disorders related to mitochondrial disease.

235 The neurobiological basis of psychogenic movement disorders remains poorly understood and the man

236 Patients with functional movement disorders requested less information to form a

237 Patients with functional movement disorders requested on average significantly fe

238 Functional movement disorders require attention to manifest yet pat

239 Chorea is a hyperkinetic movement disorder resulting from dysfunction of striatal

240 available evidence suggests that the varied movement disorders resulting from dysfunction of this ci

241 Dystonia is a common movement disorder seen by neurologists in clinic.

242 ch is characterised by progressive dementia, movement disorders, seizures and premature death.

243 ant presented with an early onset dyskinetic movement disorder, severe motor delay, and profound cogn

244 The investigation of paroxysmal movement disorders should always include the analysis of

245 ndrial homeostasis and the pathogenesis of a movement disorder similar to Parkinson's disease.

246 have been in fact reported in the setting of movement disorders, sleep disorders and even internal me

247 The Movement Disorder Society Task Force criteria were used

248 tcome was a 2 min walk, with motor symptoms (Movement Disorder Society Unified Parkinson's Disease Ra

249 ire [RBDSQ], Geriatric Depression Scale, and Movement Disorder Society Unified Parkinson's Disease Ra

250 of neurological examinations, including the Movement Disorder Society Unified Parkinson's Disease Ra

251 NMS were rated using the Movement Disorder Society Unified Parkinson's Disease Ra

252 verity and phenotype were assessed using the Movement Disorder Society Unified PD Rating Scale (UPDRS

253 The NMSs were assessed by Movement Disorder Society-sponsored revision of the Unif

254 pared with the placebo group (differences in Movement Disorder Society-sponsored revision of the Unif

255 GBA genotype and motor progression, with the Movement Disorder Society-sponsored version of the Unifi

256 l rate of change in combined scores from the Movement Disorder Society-Unified Parkinson's Disease Ra

257 The Movement Disorders Society PSP diagnostic criteria inclu

258 PD-MCI was classified using Movement Disorders Society Task Force level I (Montreal

259 cation using blinded video assessment of the Movement Disorders Society Unified Parkinson's Disease R

260 Postural Instability and Gait Disorder score-Movement Disorders Society Unified Parkinson's Disease R

261 y outcome was the adjusted difference in the Movement Disorders Society Unified Parkinson's Disease R

262 ostural instability and gait disorder score (Movement Disorders Society Unified Parkinson's Disease R

263 All cases were classified by a movement disorder specialist using defined criteria thro

264 A movement disorders specialist reviewed the complete medi

265 A movement disorders specialist reviewed the complete medi

266 A movement-disorders specialist reviewed the medical recor

267 s with Parkinson's disease were diagnosed by movement disorder specialists in accordance with the UK

268 .9 y; age range, 21-80 y) were referred from movement disorder specialists.

269 r imaging, subjects were followed by blinded movement disorders specialists for an average of 2.2 y b

270 uals with familial PD enrolled from academic movement disorder specialty clinics across the United St

271 the positive features of cranial functional movement disorders such as convergence and unilateral pl

272 xtensive efforts, half of patients with rare movement disorders such as hereditary spastic paraplegia

273 that it may contribute to motor symptoms in movement disorders such as Parkinson's disease (PD).

274 Modern functional neurosurgery for movement disorders such as Parkinson's disease, tremor,

275 ibutes to the motor symptoms of a variety of movement disorders such as Parkinson's disease.

276 Given the involvement of sodium pumps in movement disorders, such as amyotrophic lateral sclerosi

277 tive development of this system leads to eye movement disorders, such as Duane Retraction Syndrome, w

278 he general cortical neurophysiology of other movement disorders, such as essential tremor, are relati

279 The most frequently described signs were movement disorders, such as parkinsonism (12%) and dysto

280 ore the single neuron's role in epilepsy and movement disorders, surgical anesthesia, and in cognitiv

281 en January 1, 2004, and April 30, 2009, by a movement disorder team at a university hospital that rep

282 Dystonia is a neurological movement disorder that forces the body into twisting, re

283 that familial cortical myoclonus is a novel movement disorder that may be caused by mutation in NOL3

284 cortical excitability is evident in various movement disorders that compromise fine motor control.

285 Although in most movement disorders the predominant histopathology involv

286 o-bucco-lingual and cervical district by the movement disorder, the co-occurrence of cerebellar featu

287 s (SPNs) are involved in the genesis of this movement disorder, the molecular basis of dyskinesia is

288 nsights into a fascinating group of episodic movement disorders, the paroxysmal dyskinesias, and stud

289 of deep brain stimulation (DBS) for treating movement disorders, there is growing interest in using D

290 In subjects with movement disorders, this effect was observed to an even

291 what the field has uncovered thus far about movement disorders through DBS.

292 disease were diagnosed by a neurologist with movement disorder training, in accordance with the UK Pa

293 2016, in a tertiary care center's memory and movement disorders units.

294 sis as reference standard, and subjects with movement disorders versus dementia.

295 age range, 20-81 years]) with extrapyramidal movement disorders were identified.

296 Movement disorders, which include disorders such as Park

297 Essential tremor (ET) is a common movement disorder with an estimated prevalence of 5% of

298 causes an extrapyramidal, parkinsonian-type movement disorder with characteristic magnetic resonance

299 RECENT FINDINGS: Common movement disorders with ophthalmic symptoms include extr

300 he basal ganglia (BG) are implicated in many movement disorders, yet how they contribute to movement